Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - desonide, quantity: 0.5 mg/g - lotion - excipient ingredients: light liquid paraffin; propylene glycol; sorbitan monostearate; stearyl alcohol; sodium lauryl sulfate; self-emulsifying glyceryl monostearate; cetyl alcohol; methyl hydroxybenzoate; edetate sodium; propyl hydroxybenzoate; sodium hydroxide; citric acid; purified water - desowen lotion 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses for adults and children aged 2 years and older.

Spojené štáty - angličtina - NLM (National Library of Medicine)

galderma laboratories, l.p. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g - desowen® cream and lotion are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. desowen® cream and lotion are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Spojené štáty - angličtina - NLM (National Library of Medicine)

seton pharmaceuticals - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium pantothenate (unii: 568et80c3d) (pantothenic acid - unii:19f5hk2737), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag) - .beta.-carotene 1000 [iu] - se-natal 19 tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. se-natal 19 tablets are also useful in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Spojené štáty - angličtina - NLM (National Library of Medicine)

seton pharmaceuticals - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), calcium ascorbate (unii: 183e4w213w) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium pantothenate (unii: 568et80c3d) (pantothenic acid - unii:19f5hk2737), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - folic acid 1 mg - se-natal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. se-natal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Spojené štáty - angličtina - NLM (National Library of Medicine)

seton pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611), sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), calcium pantothenate (unii: 568et80c3d) (pantothenic acid - unii:19f5hk2737), zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l) - ferrous fumarate 162 mg - se-tan plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. se-tan plus is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms. pediatric use: safety and effectiveness of this product have not been established in pediatric patients. geriatric use: no clinical studies have been performed in patients age 65 and over to determine whether older persons respond differently from younger persons. dosage should always begin at the low end of the dosage scale and should consider that elderly persons may have decreased hepatic, renal, or cardiac function and or concomitant diseases.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - desonide, quantity: 0.5 mg/g - ointment - excipient ingredients: liquid paraffin; polyethylene - desowen ointment 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses for adults and children aged 2 years and older.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - desonide, quantity: 0.5 mg/g - cream - excipient ingredients: emulsifying wax; propylene glycol; stearic acid; isopropyl palmitate; synthetic beeswax; polysorbate 60; sorbic acid; potassium sorbate; propyl gallate; sodium hydroxide; citric acid; purified water - desowen cream 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses for adults and children aged 2 years and older.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; glyceryl monostearate; carmellose calcium; lactose monohydrate; maize starch; iron oxide yellow; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: carmellose calcium; hyprolose; maize starch; glyceryl monostearate; lactose monohydrate; magnesium stearate; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet, uncoated - excipient ingredients: carmellose calcium; lactose monohydrate; macrogol 8000; magnesium stearate; hyprolose; maize starch; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.